Reid, K. T., Colpitts, S. J., Mathews, J. A., Carreira, A. S., Murphy, J. M., Borovsky, D. T., . . . Crome, S. Q. Cell therapy with human IL-10-producing ILC2s limits xenogeneic graft-versus-host disease by inhibiting pathogenic T cell responses. Elsevier.
Chicago Style (17th ed.) CitationReid, Kyle T., et al. Cell Therapy with Human IL-10-producing ILC2s Limits Xenogeneic Graft-versus-host Disease by Inhibiting Pathogenic T cell Responses. Elsevier.
MLA (9th ed.) CitationReid, Kyle T., et al. Cell Therapy with Human IL-10-producing ILC2s Limits Xenogeneic Graft-versus-host Disease by Inhibiting Pathogenic T cell Responses. Elsevier.
Warning: These citations may not always be 100% accurate.